Skip to Main Content


Authored amicus brief for the Product Liability Advisory Council urging affirmance of holding that state law consumer fraud claims against drug manufacturer were preempted under the Supreme Court's impossibility preemption principles.

In re MDL 2700 Genetech Herceptin (Trastuzumab) Marketing and Sales Practices Litig., (10th Cir. 2019)
Date: 05.20.20

Stay Up To Date

Subscribe to receive news and insights from WTO.

Sign Up